Search

Charanjit Aulakh

Examiner (ID: 2304, Phone: (571)272-0678 , Office: P/1625 )

Most Active Art Unit
1625
Art Unit(s)
1612, 1625, 1203, 1621
Total Applications
3771
Issued Applications
2863
Pending Applications
382
Abandoned Applications
583

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16858685 [patent_doc_number] => 20210159430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE [patent_app_type] => utility [patent_app_number] => 16/907940 [patent_app_country] => US [patent_app_date] => 2020-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12191 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 269 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16907940 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/907940
Organic electroluminescence device and organometallic compound for organic electroluminescence device Jun 21, 2020 Issued
Array ( [id] => 20289400 [patent_doc_number] => 20250314643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-09 [patent_title] => FLUORESCENT COMPLEXES COMPRISING TWO RHODAMINE DERIVATIVES AND A NUCLEIC ACID MOLECULE [patent_app_type] => utility [patent_app_number] => 17/617037 [patent_app_country] => US [patent_app_date] => 2020-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12570 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617037 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/617037
FLUORESCENT COMPLEXES COMPRISING TWO RHODAMINE DERIVATIVES AND A NUCLEIC ACID MOLECULE Jun 18, 2020 Pending
Array ( [id] => 16376276 [patent_doc_number] => 20200325118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-15 [patent_title] => BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 RECEPTOR AND/OR M4 RECEPTOR [patent_app_type] => utility [patent_app_number] => 16/904099 [patent_app_country] => US [patent_app_date] => 2020-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74620 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904099 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/904099
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor Jun 16, 2020 Issued
Array ( [id] => 17727716 [patent_doc_number] => 11384091 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-12 [patent_title] => Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone [patent_app_type] => utility [patent_app_number] => 16/900600 [patent_app_country] => US [patent_app_date] => 2020-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16722 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16900600 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/900600
Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone Jun 11, 2020 Issued
Array ( [id] => 16657267 [patent_doc_number] => 20210053903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => APPLYING HANSEN SOLUBILITY PARAMETERS TO METAL-ORGANIC FRAMEWORK SYNTHESIS CONDITIONS [patent_app_type] => utility [patent_app_number] => 16/900109 [patent_app_country] => US [patent_app_date] => 2020-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6405 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16900109 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/900109
APPLYING HANSEN SOLUBILITY PARAMETERS TO METAL-ORGANIC FRAMEWORK SYNTHESIS CONDITIONS Jun 11, 2020 Abandoned
Array ( [id] => 16516302 [patent_doc_number] => 20200395560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-17 [patent_title] => ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND [patent_app_type] => utility [patent_app_number] => 16/899776 [patent_app_country] => US [patent_app_date] => 2020-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21498 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 1280 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899776 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/899776
Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound Jun 11, 2020 Issued
Array ( [id] => 16673068 [patent_doc_number] => 20210061831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-04 [patent_title] => COT MODULATORS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/898981 [patent_app_country] => US [patent_app_date] => 2020-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26531 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -40 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16898981 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/898981
COT MODULATORS AND METHODS OF USE THEREOF Jun 10, 2020 Abandoned
Array ( [id] => 18526348 [patent_doc_number] => 11713333 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-01 [patent_title] => Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound [patent_app_type] => utility [patent_app_number] => 16/892487 [patent_app_country] => US [patent_app_date] => 2020-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 53357 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1644 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16892487 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/892487
Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound Jun 3, 2020 Issued
Array ( [id] => 17884044 [patent_doc_number] => 20220299521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => CHEMOSELECTIVE SENSITIVITY BOOSTER FOR TAGGING A PEPTIDE, PEPTIDE CONJUGATE, OR SIMILAR REACTIVE MOLECULE [patent_app_type] => utility [patent_app_number] => 17/596208 [patent_app_country] => US [patent_app_date] => 2020-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14082 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596208 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/596208
CHEMOSELECTIVE SENSITIVITY BOOSTER FOR TAGGING A PEPTIDE, PEPTIDE CONJUGATE, OR SIMILAR REACTIVE MOLECULE Jun 3, 2020 Pending
Array ( [id] => 16516299 [patent_doc_number] => 20200395557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-17 [patent_title] => ORGANIC LIGHT-EMITTING DEVICE AND ORGANOMETALLIC COMPOUND [patent_app_type] => utility [patent_app_number] => 16/889067 [patent_app_country] => US [patent_app_date] => 2020-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29509 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 1409 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16889067 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/889067
Organic light-emitting device and organometallic compound May 31, 2020 Issued
Array ( [id] => 16540948 [patent_doc_number] => 20200407361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => TRICYCLIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/885128 [patent_app_country] => US [patent_app_date] => 2020-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35579 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16885128 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/885128
Tricyclic compounds May 26, 2020 Issued
Array ( [id] => 16777965 [patent_doc_number] => 20210115042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => ERGOLINE COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/883920 [patent_app_country] => US [patent_app_date] => 2020-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16168 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16883920 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/883920
ERGOLINE COMPOUNDS AND USES THEREOF May 25, 2020 Abandoned
Array ( [id] => 16466687 [patent_doc_number] => 20200368224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-26 [patent_title] => BUTYRYLCHOLINESTERASE INHIBITORS FOR TREATMENT OF OPIOID USE DISORDER [patent_app_type] => utility [patent_app_number] => 16/883291 [patent_app_country] => US [patent_app_date] => 2020-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6155 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16883291 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/883291
Butyrylcholinesterase inhibitors for treatment of opioid use disorder May 25, 2020 Issued
Array ( [id] => 20329683 [patent_doc_number] => 12459948 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-04 [patent_title] => Processes and intermediates for preparing a Btk inhibitor [patent_app_type] => utility [patent_app_number] => 17/612034 [patent_app_country] => US [patent_app_date] => 2020-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3128 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612034 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/612034
Processes and intermediates for preparing a Btk inhibitor May 19, 2020 Issued
Array ( [id] => 16471956 [patent_doc_number] => 20200373494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-26 [patent_title] => LIGHT-EMITTING LAYER-FORMING INK AND MANUFACTURING METHOD OF ORGANIC EL ELEMENT [patent_app_type] => utility [patent_app_number] => 16/877509 [patent_app_country] => US [patent_app_date] => 2020-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8958 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877509 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/877509
LIGHT-EMITTING LAYER-FORMING INK AND MANUFACTURING METHOD OF ORGANIC EL ELEMENT May 18, 2020 Abandoned
Array ( [id] => 18706535 [patent_doc_number] => 11793067 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-17 [patent_title] => Organometallic compound and organic light-emitting device including the same [patent_app_type] => utility [patent_app_number] => 15/930248 [patent_app_country] => US [patent_app_date] => 2020-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22189 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1364 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930248 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/930248
Organometallic compound and organic light-emitting device including the same May 11, 2020 Issued
Array ( [id] => 16268779 [patent_doc_number] => 20200270266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-27 [patent_title] => TETRAHYDROISOQUINOLINE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 16/871532 [patent_app_country] => US [patent_app_date] => 2020-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45547 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16871532 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/871532
Tetrahydroisoquinoline derivatives May 10, 2020 Issued
Array ( [id] => 16908929 [patent_doc_number] => 11040954 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-06-22 [patent_title] => CXCR3 receptor agonists [patent_app_type] => utility [patent_app_number] => 16/872161 [patent_app_country] => US [patent_app_date] => 2020-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34555 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16872161 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/872161
CXCR3 receptor agonists May 10, 2020 Issued
Array ( [id] => 18190893 [patent_doc_number] => 11581498 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-14 [patent_title] => Organic luminescent material containing 6-silyl-substituted isoquinoline ligand [patent_app_type] => utility [patent_app_number] => 16/869770 [patent_app_country] => US [patent_app_date] => 2020-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11979 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 596 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869770 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/869770
Organic luminescent material containing 6-silyl-substituted isoquinoline ligand May 7, 2020 Issued
Array ( [id] => 17089709 [patent_doc_number] => 11117886 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-14 [patent_title] => Methods and intermediates for preparing therapeutic compounds [patent_app_type] => utility [patent_app_number] => 16/869653 [patent_app_country] => US [patent_app_date] => 2020-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51460 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869653 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/869653
Methods and intermediates for preparing therapeutic compounds May 7, 2020 Issued
Menu